<h1>GST Council Recommends Tax Rate Changes, Cuts Cancer Drug GST, Exempts R&D Services, Proposes B2C E-Invoicing Pilot.</h1> The 54th GST Council meeting recommended several changes to streamline tax rates and compliance. Key decisions include forming a Group of Ministers to address GST issues in life and health insurance, reducing GST on certain cancer drugs from 12% to 5%, and exempting research and development services by government entities from GST. The Council also proposed a pilot for B2C e-invoicing, clarified GST rates on various goods and services, and introduced measures to facilitate trade, such as waiving penalties for specific tax demands. Additionally, amendments to rules and procedures were recommended to improve tax administration and compliance.